Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000834237-22-010245
Filing Date
2022-07-08
Accepted
2022-07-08 16:56:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 us3755581036_070822.txt SC 13G 11944
  Complete submission text file 0000834237-22-010245.txt   13746
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Subject) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42340 | Film No.: 221075004
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies